Karen Knudsen: Celebrating Dispatch Bio and the PICI Model in Action
Karen Knudsen, Chief Executive Officer at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn by Dispatch Bio, adding:
“Big advances to announce today! At the Parker Institute for Cancer Immunotherapy (PICI), we know that science isn’t enough – we have to get those discoveries to people.
Our unique PICI model supports innovative cancer research and fast-tracks breakthrough discoveries from the lab into early-stage company formation. The goal? Accelerate patient access to life-saving cancer therapies.
Toward that end, I’m thrilled to celebrate the public launch of Dispatch Bio, a company founded via PICI with $216M raised to date and an ambitious goal aligned to our philosophy: developing curative immunotherapy for solid tumors, which make up roughly 90% of all cancer cases.
Dispatch Bio is a perfect illustration of the PICI model in action – team science, meaningful translation, and patient-focused company creation.
Congrats to CEO Sabah Öney, founders Carl June, Kole Roybal, K. Christopher Garcia, Andy Minn, and the entire Dispatch Bio team. This is why we do science, and the kind of progress patients can’t wait for. Onward!”
Quoting Dispatch Bio’s post:
“Immunotherapy treatments have revolutionized the treatment of certain blood cancers, but increasing their impact requires addressing challenges in treating solid tumors, which make up approximately. 90% of cancers worldwide.
Dispatch is engineering a groundbreaking, universal treatment across solid tumors with a powerful, novel immunotherapy approach, aiming to profoundly expand the number of cancer patients who may benefit from the curative potential of immunotherapy through the company’s first-in-class Flare platform.
Proceed to the video attached to the post.
More posts featuring Karen Knudsen.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023